Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the ...

According to the latest Center for Information and Study on Clinical Research Participation (CISCRP) report, “having to travel to the study clinic” is patients’ top-cited participation ...

Apple has the FDA authorisation it needs to bring its software for detecting sleep apnoea to the Apple Watch, coinciding with the launch of its new operating system for the wearable. The Breathing ...

Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...

After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National ...

From grave robbers and penicillin to robotic limbs and cloned sheep, Scotland has lent a hand to some of history’s most important medical innovations. Deep Dive editor Eloise McLennan tracks the ...

Click Therapeutics' digital therapeutic (DTx) for migraine has hit the mark in a late-stage study using an endpoint commonly used to test drug therapies, which it claims is a first for the ...

Optimizing Lead Discovery, Structural Analysis & Preclinical Modeling to Successfully Develop Stable, Effective & Orally Bioavailable Small Molecule RNA Drugs for Robust Translation into the ...

In a landmark development, world leaders meeting at the United Nations officially adopted a political declaration on antimicrobial resistance (AMR), which includes a target of a 10% cut in deaths ...

September is the perfect time to turn up the volume on conversations about Primary Biliary Cholangitis (PBC) and the symptoms people living with it experience, in support of PBC Awareness Month.

The role of medical affairs in the pharmaceutical industry is evolving rapidly, taking on greater strategic importance. Here, Christoph Bug, vice president of global medical at Veeva, and Pascal ...

The consultation on raising the threshold suggests that this change will “ensure that the BIT continues to target those ...